DRKS00005376已完成不适用
Immunological and molecular Characterization of lung tumour - MP-IL-35
niversitätsklinikum ErlangenAnästhesieAbteilung Molekulare Pneumologie0 个研究点目标入组 153 人开始时间: 2013年11月13日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 153
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Further inclusion criteria
- •Patients with suspicion of/ or diagnosed lung tumor with medical indication for
- •1) VATS (video-assisted thoracoscopic surgery) or open surgical procedure on the lung and
- •2) taking blood and/or
- •3) performance of a bronchoscopy with bronchoalveolar lavage
排除标准
- •- limited coagulation (Quick<50%, PTT>50s, thrombocytes<100000/µl)
- •- limited kidney function (creatinine Kreatinin > 1,5mg/dl)
- •- pregnancy
- •- nursing period
- •- limited or non-existent compliance ability
- •- amyloidosis (SSA), family-related polyneuropathy (FAP) and family-related cardiomyopathy
- •- other severe diseases
研究者
相似试验
进行中（未招募）
不适用
Investigation of immune mechanisms relating to lapatinib associated hepatotoxicity (liver toxicity)The subjects participated in the EGF105485 study, a randomized, placebo-controlled study of lapatinib in HER2-positive early-stage breast cancer. During participation in this study, subjects had blood test results that may be suggestive of liver damage.EUCTR2013-000572-15-ESGlaxoSmithKline, S.A.75
进行中（未招募）
不适用
Investigation of immune mechanisms relating to lapatinib associated hepatotoxicity (liver toxicity)EUCTR2013-000572-15-DKGlaxoSmithKline Research & Development Ltd75
尚未招募
不适用
Immune-mediated pathogenesis and development of autoimmunity in neurological manifestations of COVID-19ONG COVID, cognitive deficits during COVID-19 infection, psychiatric disease after COVID-19 infection, immunological marker and divergence in serum and cerebro spinal fluid during COVID infectionU07.1COVID-19, virus identifiedDRKS00024434niversity of Cologne150
已完成
不适用
Histological and Microbiological Evaluation of Late Occurring Nodules with Hyaluronic Acid Dermal FillersbumpNodule1000401810014982NL-OMON50302Allergan (North America)3
尚未招募
2 期
Examinations for immune-biological mechanism of anti-atherosclerotic effects of omega 3 lipid formula, Lotriga, focusing on commensal microbe and serum auto-antibodies.The subjects with hyper-triglyceridemia and atherosclerosis.JPRN-UMIN000032320Yokohama City University Graduate School of Medicine, Department of Medical Science and Cardio-Renal Medicine36